Latest news

Filter News Articles

Conditions






Topics




















Australian research projects progress with new funding

Australian MS research projects progress with new funding, thanks to our support of MSRA.

Read more

MSWA is the leading contributor to neurological research in WA and the leading state contributor to MS Research Australia (MSRA).
MSWA’s commitment to research

Did you know we are Western Australia’s leading contributor to neurological research?

Read more

Ros Harman has been named MSWA’s President of the Board, following George Pampacos’ recent resignation from the position.

Read more

MSWA Board Member nominated for WA Australian of the Year

MSWA Board Member Professor William Carroll AM has been nominated for the 2021 WA Australian of the Year.

Read more

MSWA Board Member Professor William Carroll AM.
Demystifying demyelinating diseases

MSWA is proud to continue funding the Perron Institute’s Demyelinating Diseases Research group and they have been active across many areas in 2020, with members working both independently and collaboratively towards shared targets.

Read more

Perron Institute Allan Kermode.
Toxicity study for neuroprotective stroke treatment

MSWA is proud to have contributed funding towards collecting data for a potential neuroprotective drug for stroke and other conditions.

Read more

Neville Knuckey and Bruno Meloni Perron Institute Lab for MSWA.
Australian Government approves PBS listing of Siponimod (Mayzent®) for secondary progressive MS

The Hon Greg Hunt MP has announced the listing of siponimod (Mayzent) for the treatment of SPMS on the PBS.

Read more

MSWA Medication update - PBS listing of Siponimod (Mayzent®) for secondary progressive MS.
Fighting the effects of Parkinson’s disease

Boxing workouts are becoming increasingly popular to help people living with Parkinson’s disease manage their symptoms.

Read more

Safer, more comfortable Customer transfers thanks to new equipment

Funds raised from last year’s MSWA Ocean Ride – Powered by RetraVision have been used to purchase approximately $50k worth of equipment to support Western Australians living with a neurological condition.

Read more

Western Australian research to help with the damage in the early phases of stroke

MSWA is proud to be funding this important West Australian research that will provide the first effective treatment to minimise the damage that occurs in the early phases of stroke.

Read more Watch media footage